VK5211
VK5211-201
Phase 2 small_molecule completed
Quick answer
VK5211 for Hip Fractures is a Phase 2 program (small_molecule) at Viking Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Viking Therapeutics
- Indication
- Hip Fractures
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed